148 related articles for article (PubMed ID: 9194081)
1. 67Ga scintigraphy for the evaluation of recurrences and residual masses in patients with lymphoma.
Setoain FJ; Pons F; Herranz R; Vidal-Sicart S; Lomeña F; Ayuso C; Montserrat E; Setoain J
Nucl Med Commun; 1997 May; 18(5):405-11. PubMed ID: 9194081
[TBL] [Abstract][Full Text] [Related]
2. Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy.
Delcambre C; Reman O; Henry-Amar M; Peny AM; Macro M; Cheze S; Génot JY; Tanguy A; Switsers O; Van HL; Couëtte JE; Leporrier M; Bardet S
Eur J Nucl Med; 2000 Feb; 27(2):176-84. PubMed ID: 10755723
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of whole body FDG-PET on the staging and therapeutic decision making for malignant lymphoma.
Sasaki M; Kuwabara Y; Koga H; Nakagawa M; Chen T; Kaneko K; Hayashi K; Nakamura K; Masuda K
Ann Nucl Med; 2002 Jul; 16(5):337-45. PubMed ID: 12230093
[TBL] [Abstract][Full Text] [Related]
4. [Effectiveness of (67)Ga scintigraphy in the diagnosis of lymphoma relapse].
Alvarez Ruiz S; Rodeño Ortiz De Zárate E; Alonso Colmenares I; Cortés Hernández J; Alcorta P
Rev Esp Med Nucl; 2002 Apr; 21(2):88-92. PubMed ID: 11879616
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging and 67Ga scan versus computed tomography in the staging and in the monitoring of mediastinal malignant lymphoma: a prospective pilot study.
Bendini M; Zuiani C; Bazzocchi M; Dalpiaz G; Zaja F; Englaro E
MAGMA; 1996; 4(3-4):213-24. PubMed ID: 9220410
[TBL] [Abstract][Full Text] [Related]
6. Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
Zinzani PL; Zompatori M; Bendandi M; Battista G; Fanti S; Barbieri E; Gherlinzoni F; Rimondi MR; Frezza G; Pisi P; Merla E; Gozzetti A; Canini R; Monetti N; Babini L; Tura S
Leuk Lymphoma; 1996 Jun; 22(1-2):131-5. PubMed ID: 8724540
[TBL] [Abstract][Full Text] [Related]
7. Bone lymphoma: 67Ga scintigraphy and CT for prediction of outcome after treatment.
Israel O; Mekel M; Bar-Shalom R; Epelbaum R; Hermony N; Haim N; Dann EJ; Frenkel A; Ben-Arush M; Gaitini D
J Nucl Med; 2002 Oct; 43(10):1295-303. PubMed ID: 12368366
[TBL] [Abstract][Full Text] [Related]
8. Gallium-67 scintigraphy in lymphoma: is there a benefit of image fusion with computed tomography?
Chajari M; Lacroix J; Peny AM; Chesnay E; Batalla A; Henry-Amar M; Delcambre C; Génot JY; Fruchard C; Bardet S
Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):380-7. PubMed ID: 12002715
[TBL] [Abstract][Full Text] [Related]
9. The continuing clinical role of gallium 67 scintigraphy in the age of receptor imaging.
Front D; Bar-Shalom R; Israel O
Semin Nucl Med; 1997 Jan; 27(1):68-74. PubMed ID: 9122725
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of pretransplantation computed tomography and gallium scans in patients with Hodgkin lymphoma with poor prognosis undergoing hematopoietic stem cell transplantation.
Escobar IG; Barrigon DC; Tamayo P; Perez-Simon JA; Mateos MV; Garcia JR; San Miguel JF
Clin Lymphoma Myeloma; 2006 Nov; 7(3):217-25. PubMed ID: 17229338
[TBL] [Abstract][Full Text] [Related]
11. The role of high dose 67-gallium scintigraphy in staging untreated patients with lymphoma.
Larcos G; Farlow DC; Antico VF; Gruenewald SM; Boyages J
Aust N Z J Med; 1994 Feb; 24(1):5-8. PubMed ID: 8002858
[TBL] [Abstract][Full Text] [Related]
12. Utility of gallium-67 scintigraphy in low-grade non-Hodgkin's lymphoma.
Ben-Haim S; Bar-Shalom R; Israel O; Haim N; Epelbaum R; Ben-Shachar M; Gaitini D; Kolodny GM; Front D
J Clin Oncol; 1996 Jun; 14(6):1936-42. PubMed ID: 8656263
[TBL] [Abstract][Full Text] [Related]
13. [False-positive findings of 67-gallium scintigraphy in staging/restaging of malignant lymphoma].
Bihl H; Kimmig B
Rofo; 1987 Feb; 146(2):172-7. PubMed ID: 3029830
[TBL] [Abstract][Full Text] [Related]
14. Aggressive non-Hodgkin lymphoma: early prediction of outcome with 67Ga scintigraphy.
Front D; Bar-Shalom R; Mor M; Haim N; Epelbaum R; Frenkel A; Gaitini D; Kolodny GM; Israel O
Radiology; 2000 Jan; 214(1):253-7. PubMed ID: 10644133
[TBL] [Abstract][Full Text] [Related]
15. Early detection of lymphoma recurrence with gallium-67 scintigraphy.
Front D; Bar-Shalom R; Epelbaum R; Haim N; Ben-Arush MW; Ben-Shahar M; Gorenberg M; Kleinhaus U; Parmett S; Kolodny GM
J Nucl Med; 1993 Dec; 34(12):2101-4. PubMed ID: 8254395
[TBL] [Abstract][Full Text] [Related]
16. Value of combined 67Ga and 99Tc(m)-human immunoglobulin G whole-body scanning in malignant lymphoma.
Küçük NO; Aras G; Soylu A; Ozcan M; Ibis E; Dinçol D
Nucl Med Commun; 2001 Mar; 22(3):325-9. PubMed ID: 11314766
[TBL] [Abstract][Full Text] [Related]
17. Value of low-dose gallium-67 imaging in detection of non-Hodgkin's lymphoma recurrence.
Nakayama M; Sakahara H; Minowa Y; Sasai K; Ishigaki T; Saga T; Nakamoto Y; Yao Z; Hiraoka M; Sakai K; Konishi J
Radiat Med; 1997; 15(2):79-83. PubMed ID: 9192431
[TBL] [Abstract][Full Text] [Related]
18. The role of Ga-67 scintigraphy in evaluating the results of therapy of lymphoma patients.
Front D; Israel O
Semin Nucl Med; 1995 Jan; 25(1):60-71. PubMed ID: 7716559
[TBL] [Abstract][Full Text] [Related]
19. [SPECT-CT 67Ga studies in lymphoma disease. Contribution to staging and follow-up].
Fuertes Manuel J; Estorch Cabrera M; Camacho Martí V; Flotats Giralt A; Rodríguez-Revuelto AA; Hernández Fructuoso MA; Carrió Gasset I
Rev Esp Med Nucl; 2006; 25(4):242-9. PubMed ID: 16827987
[TBL] [Abstract][Full Text] [Related]
20. [Assessment of residual mediastinal tumor in patients with Hodgkin's lymphoma using computed tomography, magnetic resonance and 67Ga scintigraphy].
Capua A; Osti MF; Scattoni Padovan F; Sarra R; Sbarbati S; Anselmo AP; Maurizi Enrici R
Radiol Med; 1995 Dec; 90(6):797-803. PubMed ID: 8685466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
